Cargando…
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were obtained from 58 patients at the time of diagnosis an...
Autores principales: | Hammouda, Nada E., Salah El-Din, Manal A., El-Shishtawy, Mamdouh M., El-Gayar, Amal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388146/ https://www.ncbi.nlm.nih.gov/pubmed/28282874 http://dx.doi.org/10.3390/scipharm85010009 |
Ejemplares similares
-
Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022) -
Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma
por: Amhimmid Badr, Sana, et al.
Publicado: (2018) -
Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children
por: Hamed, Hanan M., et al.
Publicado: (2013) -
Endostatin and
Cystatin C as Potential Biomarkers
for Early Prediction of Preeclampsia
por: Alshannag, Fatima, et al.
Publicado: (2023) -
Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus
por: Assal, Heba S., et al.
Publicado: (2013)